Abstract:
This article presents a literature review on the risk of cardiovascular disease related to
contraceptives. The study aimed to discuss and identify the main scientific evidence
linking the use of combined oral contraceptives to the occurrence of cardiovascular
events, such as myocardial infarction, deep vein thrombosis, and stroke. The
methodology used was a review of scientific literature published between 2015 and2025, obtained through the BDTD (Brazilian Digital Library of Theses and
Dissertations) database, using the descriptors “oral contraceptives” and
“cardiovascular risks”. The results indicated that prolonged use of combined oral
contraceptives, especially those containing estrogen and progestin, may increase the
risk of thromboembolic events, particularly in obese women, smokers, or those with a
family history of cardiovascular disease. Although oral contraceptives are widely used
and effective in preventing pregnancy, an evaluation by medical and pharmaceutical
professionals is essential before prescribing them, considering each patient's
individual risk profile.
